Ultrasound Treatment for Prostate Cancer Has Early Advantage Versus Prostatectomy
An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical prostatectomy in an early analysis of a first-ever randomized trial. After 6 months of follow-up, twice as many patients treated with MRI-guided transurethral ultrasound ablation (TULSA) met the composite primary safety endpoint of pad-free urinary continence and preserved erectile function…
